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Background: Halitosis is a common problem that affects a large portion of the population worldwide. The origin of
this condition is oral in 90% and systemic in 10% of cases. The unpleasant odor is mainly the result of volatile sulfur
compounds produced by Gram-negative bacteria. However, it has recently been found that anaerobic Gram-positive
bacteria also produce hydrogen sulfide (H2S) in the presence of amino acids, such as cysteine. Light, both with and
without the use of chemical agents, has been used to induce therapeutic and antimicrobial effects. In photodynamic
therapy, the antimicrobial effect is confined to areas covered by photosensitizing dye. The aim of the present study is
to evaluate the antimicrobial effect of photodynamic therapy on halitosis in adolescents through the analysis of volatile
sulfur compounds measured using gas chromatography and microbiological analysis of coated tongue.
Methods/Design: A quantitative clinical trial will be carried out involving 60 adolescents randomly divided into the
following groups: group 1 will receive treatment with a tongue scraper, group 2 will receive photodynamic therapy
applied to the posterior two-thirds of the dorsum of the tongue, and group 3 will receive combined treatment (tongue
scraper and photodynamic therapy). Gas chromatography (OralChromaTM) and microbiological analysis will be used for
the diagnosis of halitosis at the beginning of the study. Post-treatment evaluations will be conducted at one hour and
24 hours after treatment. The statistical analysis will include the Shapiro-Wilk test for the determination of the distribution
of the data. If normal distribution is demonstrated, analysis of variance followed by Tukey’s test will be used to compare
groups. The Kruskal-Wallis test followed by the Student-Newman-Keuls test will be used for data with non-normal
distribution. Either the paired t-test or the Wilcoxon test will be used to compare data before and after treatment,
depending on the distribution of the data.
Discussion: The results of this trial will determine the efficacy of using photodynamic therapy alone or in combination
with a tongue scraper to treat bad breath in adolescents.
Trial registration: The protocol for this study was registered with Clinical Trials (registration number NCT02007993) on
10 December 2013.
Keywords: Halitosis, Photodynamic therapy, Adolescent* Correspondence: sandra.skb@gmail.com
University Nove de Julho, Rua Vergueiro, 235, Liberdade, São Paulo, SP
01504-000, Brazil
© 2014 Lopes et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Lopes et al. Trials 2014, 15:443 Page 2 of 7
http://www.trialsjournal.com/content/15/1/443Background
Halitosis is a term used to define an unpleasant odor that
emanates from the mouth, stemming from either a local
or systemic origin [1-3]. This common problem affects a
large portion of the population worldwide and causes con-
siderable embarrassment. Therefore, halitosis has a nega-
tive impact on social communication and quality of life
[4]. The lack of standardization in the protocol for the
diagnosis and treatment of halitosis hinders the compari-
son of data from epidemiological studies conducted in dif-
ferent countries and yet it is believed that 25% of the
population are affected by this condition [5].
Studies on the etiology of halitosis report that 2% of
cases stem from renal, metabolic, hepatic, endocrino-
logical and gastrointestinal disorders (such as infection
by Helicobacter pylori and intestinal blockage), and 8%
are due to conditions of the respiratory system and con-
ditions of the ears, nose and throat (ENT), such as acute
tonsillitis, postnasal drip, sinusitis and tonsillolith. The ma-
jority of cases (80 to 90%) are directly linked to conditions
of the oral cavity, such as periodontal disease, coated tongue,
poor oral hygiene, salivary abnormalities (change in pH and
hyposialy), stomatitis, intra-oral neoplasm, pulp exposure,
extraction wounds and crowding of the teeth [5-8].
Bad breath mainly stems from volatile sulfur com-
pounds (VSCs) produced by the action of anaerobic
Gram-negative bacteria (Fusobacterium nucleatum, Sele-
nomonas, Treponema denticola, Prevotella intermedia,
Tannerella forsythyia, Porphyromonas gingivalis, Bacter-
oides forsythus and Eubacterium) found in the oral cavity
on substrates containing sulfur [9-11]. The VSCs pro-
duced by the metabolism of these bacteria are hydrogen
sulfide (H2S), found mainly on the dorsum of the
tongue, methanethiol (CH3SH) in gingival pockets and
dimethyl sulfide (CH3SCH3), which has an extra-oral
origin [12-15]. The concentration of these compounds is
used as an indicator of halitosis [3,16].
Recently, the anaerobic Gram-positive bacterium Solo-
bacterium moorei (also known as Bulleidia moorei) has
been associated with halitosis due to the production of
H2S in the presence of different supplements containing
amino acids, especially cysteine [17,18]. Studies have dem-
onstrated that the presence of these bacteria on the dor-
sum of the tongue, as well as in saliva and periodontal
pockets, can lead to both halitosis and systemic problems
such as complications during pregnancy, cardiovascular dis-
ease and chronic lower respiratory infection [19], which is
considered the third most common cause of death [2,20-23].
Detection
Two main methods are used to evaluate halitosis: a
subjective (organoleptic) evaluation and an objective
evaluation (quantitative measure of VSCs, gas chroma-
tography (GC) and monitor analysis) [24-27]. Studiescomparing the efficacy of these methods report GC to
be the most objective and efficacious method for the
individual detection of H2S, CH3SH and CH3SCH3,
allowing the evaluation of both the intensity of bad
breath and its origin [5,15]. Indeed, GC is currently
considered the gold standard for the detection of hali-
tosis [11]. However, the majority of researchers have
used a combination of both subjective and objective
evaluations, whereas others have only used an organo-
leptic evaluation due to its ease of execution and low
cost [24]. Halitosis can be analyzed using a sulfide
monitor, such as the Halimeter (Interscan Corporation,
Chatsworth, California, United States) [3,4,26-28], which
determines the total amount of VSCs in parts per billion
(ppb) under normal conditions.Photodynamic therapy
Photodynamic therapy (PDT) was discovered in 1900 by
Oskar Raab and Hermann von Tappeiner. In the 1970s,
PDT began to be used for the treatment of cancer. Re-
cently, antimicrobial PDT has been used as a treatment
option for localized infections [29]. PDT involves the use
of a non-toxic light-sensitive photosensitizer combined
with visible light at the appropriate wavelength to coincide
with the absorption spectrum of the photosensitizer,
which reaches a state of excitation after absorbing the
photons, reacting with the oxygen in the medium to form
reactive oxygen species. This phototoxic reaction induces
the destruction of bacterial cells. The antimicrobial effect is
confined to areas covered by the light-activated photosensi-
tizer, quickly acting on the target organisms when the ap-
propriate energy dose and output power are used [9,29-33].
According to Wainwright [34], bacterial resistance to PDT
is unlikely, as the singlet oxygen and free radicals formed
interact with different bacterial cell structures and different
metabolic pathways [32,33].
The conventional treatment of halitosis related to oral
conditions consists of the chemical reduction of micro-
organisms with a mouthwash, such as 0.2% chlorhexi-
dine, essential oils, triclosan and hydrogen peroxide, the
mechanical removal of nutrients with a tongue scraper
or brush, the masking of odor with chewing gum, mints
and breath spray, and the transformation of VSCs using
zinc plus chlorhexidine [2,5,10,12,35-37]. However, the
irregular characteristics of the surface of the dorsum of
the tongue make the adequate reduction in bacterial a
particular challenge [2,36,38].
Considering the scarcity of studies addressing the
effect of PDT on tongue biofilm, the aim of the
present study was to evaluate the effectiveness of
PDT on the dorsum of the tongue in adolescents with
halitosis by an analysis of VSCs and microbiological
analysis of the tongue.
Figure 1 Flowchart of study. P = output power; E = energy and
T = time in seconds.
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This study will be carried out in compliance with regula-
tory norms governing research involving human subjects.
Approval was obtained from the Human Research Ethics
Committee of University Nove de Julho (Brazil) under
process number 037315/2013, and the study is registered
with the United States National Institutes of Health
(Clinical Trials.gov registration number: NCT02007993).
The guardians of the participants will be informed regard-
ing the procedures and will sign a statement of informed
consent authorizing the participation of their sons and
daughters in compliance with Resolution 196/96 of the
Brazilian National Health Board.
Male and female adolescents enrolled at the dental clinic
of the university will be recruited for the study. Those
aged between 13 and 18 years, with a diagnosis of halitosis
and OralChroma™ results of H2S ≥112 ppb during the
cysteine challenge [11,15,39,40] will be included. The ex-
clusion criteria will be [41] dentofacial anomalies, cur-
rently undergoing orthodontic or orthopedic treatment,
current use of a removable appliance, implant or dentures,
periodontal disease, teeth with carious lesions, currently
undergoing cancer treatment, diabetes mellitus, systemic
(gastrointestinal, renal or hepatic disorder) conditions, ear,
nose or throat conditions, respiratory conditions, anti-
biotic therapy in the previous month, current pregnancy
[5] or hypersensitivity to the photosensitizer. As this is a ran-
domized clinical trial, the recommendations of the Consoli-
dated Standards of Reporting Trials (CONSORT) will be
used to ensure greater transparency and quality (Figure 1).
The subjects selected will be randomly allocated to three
groups (Table 1). All individuals will be submitted to eval-
uations with OralChroma™ before and after treatment.
Microbiological analysis
Microbiological analyses of coated tongue will be performed
before and after treatment using a 1-μl inoculation loop for
the collection of biofilm samples from the dorsum of the
tongue. The samples will be transferred to 1.5-ml vials with
reduced transport fluid and placed in a vortex mixer (Prolab,
São Paulo – Brazil) for approximately 30 seconds for
homogenization. Ten-fold serial dilution will be prepared in
180 μl of sterile phosphate buffered saline (Probac, São
Paulo – Brazil) and aliquots of 10−2, 10−3, 10−4 and
10−5 will be transferred to plates with brain-heart infusion
agar (Probac, São Paulo – Brazil). As the main bacteria
responsible for the production of VSCs are Gram-negative,
the plates will be incubated in anaerobic jar for 72 hours at
37°C, following by the quantification of colony-forming
units [10,42].
Halitosis detection
The literature describes a number of methods for meas-
uring halitosis, such as an organoleptic evaluation of theair emanating from the oral cavity [16,26] using a sulfide
monitor [16,25,43] or GC [11,43,44]. However, it has been
demonstrated that the organoleptic test can be influenced
by the olfactory capacity and emotional state of the exam-
iner, as well as climatic conditions [3]. Therefore, the port-
able OralChroma™ device Abilit Corporation, Chuo-ku,
Osaka - Japan) will be employed. This device uses a highly
sensitive gas semiconductor sensor.
Table 1 Summary of experimental conditions
Group Halitosis Treatment
1 H2S ≥112 ppb Tongue scraper
2 H2S ≥112 ppb PDT
E = 9 J T = 90 s
3 SH2≥ 112 ppb Tongue scraper + PDT
E = 9 J T = 90 s
H2S = hydrogen sulfide; ppb = part per billion; PDT = photodynamic therapy;
E = energy; T = time in seconds.
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Ação, São Paulo – Brazil) for one minute (cysteine
10 mM - 16 mg of cysteine in 100 ml of distilled water -
16% mg). A syringe will be placed in the participant’s
mouth with the plunger completely inserted. The partici-
pant will close his or her mouth, breathe through the nose
and remain still with the mouth closed for one minute.
The participant will be instructed not to touch the tip of
the syringe with his or her tongue. The plunger will then
be withdrawn, pushed back in to empty the air into the
participant’s mouth and will be withdrawn again to fill the
syringe with the breath sample. The tip of the syringe will
be cleaned to remove saliva and a gas injection needle will
be placed on the syringe. The plunger will be adjusted to
0.5 ml and the contents will be injected into the input of
the device in a single motion (Figure 2) [15].Analysis of VSCs
OralChroma™ (Abilit Corporation) was developed in Japan
for the individual determination of H2S, CH3SH and
CH3SCH3, allowing for the evaluation of both the intensity
of bad breath and its origin [5,11,15]. H2S originatesFigure 2 Process for the acquisition of the sample for the halimetric.
OralChroma™ will be connected to the computer with a specific software
peaks and concentrations of VSCs (0 to 2913 ppb) with considerable prec
well as in the device itself, and can be retrieved at any time for comparismainly from bacteria on the dorsum of the tongue. Values
greater than 112 ppb indicate halitosis. CH3SH is found in
greater concentration in periodontal pockets. Values up to
26 ppb are considered normal. Periodontal disease typic-
ally results in a high CH3SH:H2S ratio (>3:1). CH3SCH3
may have a periodontal or systemic (intestine, liver or
lung) origin and may also be temporarily caused by the in-
gestion of certain foods and beverages. The distinction be-
tween CH3SCH3 of an oral or systemic origin can be
made through the comparison of the results of the hali-
metric (OralChroma™) with and without a cysteine chal-
lenge. The perception threshold for CH3SCH3 is very low
(8 ppb). Other non-VSC odors may appear in a peak prior
to the theoretical first peak, which is H2S [15].
To maximize the standardization of the readings, the
exam will be carried out in the morning and the partici-
pants will be instructed to avoid the ingestion of foods with
garlic, onion or strong spices, as well as the consumption
of alcohol and the use of an antiseptic mouthwash. On the
morning of the exam, more than two hours should have
passed since any food intake and the participants are to ab-
stain from coffee, hard candy, chewing gum, oral hygiene
products and personal care items containing fragrances
(aftershave, deodorant, perfume and creams). Brushing will
be performed with water alone [27,45].
Photodynamic therapy
The THERAPY XT-ES™ (DMC ABC Medical and Dental
Equipment, São Paulo, Brazil) with a red (660 nm) and
infrared (810 nm) laser and a fine tip (for regions of dif-
ficult access) will be used. Only the volunteer and oper-
ator will be present at the time of PDT and both will be
wearing protective eyewear. The active point of the laser
will be covered with disposable clear plastic wrap (PVC)OralChroma (Abiliti Corporation, Chuo-ku, Osaka – Japan). The
program that allows the creation of a graph corresponding to the
ision after eight minutes. The results are stored in the program, as
ons of the readings before, during and after treatment.
Table 2 Parameters of laser
Parameter Red laser
Center wavelength (nm) 660
Spectral bandwidth (FWHM) (nm) 5
Operating mode Continuous wave
Average radiant power (mW) 100
Polarization Random
Aperture diameter (cm) 0.094
Irradiance at aperture (mW/cm2) 3537
Beam profile Multimode
Beam spot size at target (cm2) 0.02827
Irradiance at target (mW/cm2) 3537
Exposure duration (s) 90/120
Radiant exposure (J/cm2) 320/428
Radiant energy (J) 9/12
Number of points irradiated 9
Area irradiated (cm2) 0.254
Application technique Contact
Number and frequency of treatment sessions 1 session
Total radiant energy (J) 81/108
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The operator will use the appropriate clothing.
A single session of PDT will be performed with the
Chimiolux™ methylene blue photosensitizer (DMC ABC
Medical and Dental Equipment, São Paulo, Brazil) at a
concentration of 0.005% (165 μm) applied to the middle
and posterior thirds of the dorsum of the tongue. After
five minutes of pre-irradiation time for incubation, the
excess will be removed with an aspirator to maintain
the surface moist with the photosensitizer alone (without
the use of water). A total of six points will be irradiated
(Figure 3). Based on studies developed for the treatment
of periodontal disease with PDT [46-52] and a previous
pilot study [53], the device will be calibrated with a wave-
length of 660 nm, power output of 100 mW, fluency of
320 J/cm2, irradiance of 3537 mW/cm2 and an energy
dose of 9 joules for 90 seconds per point in groups 2 and
3. The punctual application method will be used with the
conventional tip in contact with the tongue (Table 2).
Tongue scraping intervention
A Halicare™ tongue scraper (Odomed, São Paulo, Brazil)
will be used for the removal of biofilm. The participant
will be instructed to divide the tongue into two parts
and scrape each side 10 times (Figure 4).
Calculation of sample size
The error was established as err ¼ x1− x2j j , in which x1
and x2 are the means of groups 1 and 2. Assuming bothFigure 3 Points of photodynamic therapy application.samples as having the same size (n1 = n2), the sample
size is obtained from the following equation:





in which σ21 and σ
2
1 are the variances in groups 1 and 2,
respectively. As more than two groups will be studied, the
decision was made to employ the largest error found in
the literature [54] to estimate the sample size. Assuming
all groups as having normal or approximately normal dis-
tribution, and that the sample will be large enough for a
significance level of α = 0.05, the Z value was determined
to be 1.96. However, for the sample size, the test power
was established as 1-β = 0.80. In case the hypothesis of
normality in the samples was rejected, the sample size was
corrected by 5%. Based on the experimental groups in the
study by Tsai et al. [54] it was determined that each group
should contain 26 participants (n = 26).Outcome measures
Only participants with H2S ≥112 ppb, CH3SH ≤26 ppb
and CH3SCH3 ≤ 8 ppb will be part of the research, which
limits participation to individuals with halitosis caused
by coated tongue alone. Immediately after treatment, a
second halimetry test will be performed and the results
will be analyzed.
Figure 4 Diagram of tongue scraper use.
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Our null hypothesis is that there will be no change in
halitosis following the use of PDT. Our experimental hy-
pothesis is that there will be a reduction in halitosis fol-
lowing the use of PDT alone or in combination with a
tongue scraper.
Organization and statistical analysis of data
The Shapiro-Wilk test will be used to determine the
distribution of the halimetricdata. If the data presents
with normal distribution, analysis of variance (ANOVA)
followed by the Tukey test will be used to evaluate the
correlation between each of the proposed treatments
and halitosis. The paired t-test will be used to compare
the data before and after each treatment and determine
whether the treatments reduced the degree of halitosis.
The Kruskal-Wallis test followed by the Student-
Newman-Keuls test will be used for data with non-
normal distribution, and the Wilcoxon test will be used
to analyze the data before and after each treatment.
Microbiological data presents with log-normal distribu-
tion and will therefore be analyzed using the methods
described for data with normal distribution. A signifi-
cance level of α = 0.05 will be used.
Discussion
The main objective of the proposed study is to evaluate
the effect of PDT with and without the use of a tongue
scraper for the treatment of halitosis in adolescents. This
objective has two aspects: the evaluation of VSC levels
before and after treatment through a quantitative ana-
lysis of H2S using GC, and a microbiological analysis of
the effect of PDT on coated tongue. The findings areexpected to provide convincing evidence that PDT is
more effective for the treatment of halitosis.
In the literature, the treatment of halitosis is performed
using a tongue scraper with or without a mouthwash [2],
which leads to a small, long-term reduction in the amount
of bacteria on the tongue [38]. Thus, daily oral hygiene is
needed to maintain a low level of bacterial proliferation. As
the penetration of light and spreading of the photosensi-
tizer do not seem to be affected by the posterior papillae of
the tongue, treatment with PDT is promising and may
achieve satisfactory results, especially when combined with
conventional treatment.
Trial status
The authors are currently recruiting participants. It begun
on March of 2014 and we pretend to go until August of
2015.
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